| scholarly article | Q13442814 |
| P356 | DOI | 10.1053/JHEP.2003.50196 |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1053%2Fjhep.2003.50196 |
| https://onlinelibrary.wiley.com/doi/full/10.1053/jhep.2003.50196 | ||
| P698 | PubMed publication ID | 12717387 |
| P5875 | ResearchGate publication ID | 10785982 |
| P50 | author | Rolf Gebhardt | Q99628521 |
| P2093 | author name string | Hermann Bujard | |
| Kai Schönig | |||
| Elke Ueberham | |||
| Uwe Ueberham | |||
| Rainer Löw | |||
| P2860 | cites work | The New England Journal of Medicine | Q582728 |
| American Journal of Physiology | Q2160146 | ||
| Journal of Immunology | Q3521441 | ||
| Journal of Physiology | Q7743612 | ||
| Tight control of gene expression in mammalian cells by tetracycline-responsive promoters | Q24564850 | ||
| Cytokines and fibrogenesis | Q33697040 | ||
| Is liver fibrosis reversible? | Q33862568 | ||
| Autocrine induction of tumor protease production and invasion by a metallothionein-regulated TGF-beta 1 (Ser223, 225) | Q33937674 | ||
| Extracellular matrix degradation and the role of hepatic stellate cells | Q34391375 | ||
| Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions | Q34480115 | ||
| Oxidative stress, plant-derived antioxidants and liver fibrosis | Q34623869 | ||
| Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro | Q35610349 | ||
| Altered balance between matrix metalloproteinases and their inhibitors in experimental biliary fibrosis | Q35785934 | ||
| In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis | Q36553502 | ||
| Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1 | Q37058555 | ||
| Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. | Q37182998 | ||
| Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice | Q37303897 | ||
| Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-beta1 transgenic mice | Q37375446 | ||
| Experimental models of hepatic fibrosis: a review | Q37812210 | ||
| Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis | Q37921927 | ||
| Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors | Q39807542 | ||
| Endotoxin, reticuloendothelial function, and liver injury | Q40320109 | ||
| Co-regulation of two gene activities by tetracycline via a bidirectional promoter. | Q40395769 | ||
| Transforming growth factor-beta 1 in reproduction and development | Q40573466 | ||
| Tet repressor-based system for regulated gene expression in eukaryotic cells: principles and advances | Q40846822 | ||
| Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta | Q42124595 | ||
| Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations | Q42279177 | ||
| Dose-dependent inhibition of hepatic fibrosis in mice by a TGF-beta soluble receptor: implications for antifibrotic therapy | Q43974807 | ||
| In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells. | Q53038196 | ||
| Inhibitory effect of transforming growth factor-beta on DNA synthesis of adult rat hepatocytes in primary culture | Q69924795 | ||
| A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues | Q70859629 | ||
| Lipopolysaccharide-neutralizing antibody reduces hepatocyte injury from acute hepatotoxin administration | Q72402221 | ||
| Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model | Q73229679 | ||
| Matrix degradation in liver: a role in injury and repair | Q73782049 | ||
| Expression of matrix metalloproteinases and their inhibitors during hepatic tissue repair in the rat | Q74136816 | ||
| Endless healing: TGF-beta, SMADs, and fibrosis | Q74601263 | ||
| Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1 | Q77932181 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tetracycline | Q193045 |
| animal disease model | Q64732998 | ||
| transgenic mice | Q69382071 | ||
| P304 | page(s) | 1067-1078 | |
| P577 | publication date | 2003-05-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis | |
| Conditional tetracycline-regulated expression of TGF-β1 in liver of transgenic mice leads to reversible intermediary fibrosis | |||
| P478 | volume | 37 |
| Q34850749 | A fibronectin-independent mechanism of collagen fibrillogenesis in adult liver remodeling |
| Q27319418 | Accelerated CCl4-induced liver fibrosis in Hjv-/- mice, associated with an oxidative burst and precocious profibrogenic gene expression |
| Q37478547 | Adenovirus E1A and E1B-19K proteins protect human hepatoma cells from transforming growth factor beta1-induced apoptosis |
| Q36247097 | An efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic mice. |
| Q34979933 | Animal models for the study of liver fibrosis: new insights from knockout mouse models |
| Q36339566 | Anti-TGF-beta strategies for the treatment of chronic liver disease |
| Q38480164 | Antifibrotic therapies in the liver |
| Q34170852 | Asiatic acid inhibits liver fibrosis by blocking TGF-beta/Smad signaling in vivo and in vitro |
| Q64257372 | Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling |
| Q35750103 | Biological Significance of Local TGF-β Activation in Liver Diseases |
| Q41110032 | Blockade of CCN4 attenuates CCl4-induced liver fibrosis |
| Q36220879 | Cell signals influencing hepatic fibrosis |
| Q44587681 | Chronically high level of tgfb1a induction causes both hepatocellular carcinoma and cholangiocarcinoma via a dominant Erk pathway in zebrafish. |
| Q36576803 | Coexpression of Smad7 and UPA attenuates carbon tetrachloride-induced rat liver fibrosis |
| Q48464562 | Conditional expression of human acid beta-glucosidase improves the visceral phenotype in a Gaucher disease mouse model |
| Q52096642 | Conditional expression of transforming growth factor-alpha in adult mouse lung causes pulmonary fibrosis. |
| Q49922983 | Critical effects of long non-coding RNA on fibrosis diseases |
| Q36020284 | Decreased body fat, elevated plasma transforming growth factor-β levels, and impaired BMP4-like signaling in biglycan-deficient mice. |
| Q42353109 | Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice |
| Q42176477 | Dynamic changes in the expression of matrix metalloproteinases and their inhibitors, TIMPs, during hepatic fibrosis induced by alcohol in rats |
| Q35405665 | Effects of 18α-glycyrrhizin on TGF-β1/Smad signaling pathway in rats with carbon tetrachloride-induced liver fibrosis |
| Q37295226 | Embryonic liver fodrin involved in hepatic stellate cell activation and formation of regenerative nodule in liver cirrhosis |
| Q81304007 | Enhanced matrix degradation after withdrawal of TGF-beta1 triggers hepatocytes from apoptosis to proliferation and regeneration |
| Q44858633 | Epigenetic histone methylation regulates transforming growth factor β-1 expression following bile duct ligation in rats. |
| Q36183787 | Establishment of an early liver fibrosis model by the hydrodynamics-based transfer of TGF-beta1 gene |
| Q40512525 | Gene Expression Patterns Associated With Histopathology in Toxic Liver Fibrosis. |
| Q35122931 | HIV-1 infected peripheral blood mononuclear cells modulate the fibrogenic activity of hepatic stellate cells through secreted TGF-β and JNK signaling |
| Q36758861 | Hepatic autophagy is differentially regulated in periportal and pericentral zones - a general mechanism relevant for other tissues? |
| Q36588244 | Hepatic stellate cells and the reversal of fibrosis |
| Q27490473 | Hepatitis C Virus (HCV) Proteins Induce NADPH Oxidase 4 Expression in a Transforming Growth Factor -Dependent Manner: a New Contributor to HCV-Induced Oxidative Stress |
| Q48121669 | Herbal Formula, Baogan Yihao (BGYH), Prevented Dimethylnitrosamine(DMN)-Induced Liver Injury in Rats. |
| Q38389648 | Hyperoxia accelerates progression of hepatic fibrosis by up-regulation of transforming growth factor-β expression |
| Q54340131 | Imatinib mesylate improves liver regeneration and attenuates liver fibrogenesis in CCL4-treated mice. |
| Q54478097 | Inhibitory effect of antisense oligonucleotide targeting TIMP-2 on immune-induced liver fibrosis. |
| Q34193125 | Inhibitory effect of liposomal quercetin on acute hepatitis and hepatic fibrosis induced by concanavalin A |
| Q24618219 | La enhances IRES-mediated translation of laminin B1 during malignant epithelial to mesenchymal transition |
| Q39834604 | Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells |
| Q29547449 | Liver fibrosis |
| Q36720404 | Long noncoding RNAs expressed in human hepatic stellate cells form networks with extracellular matrix proteins |
| Q80188297 | Matrix metalloproteinase-9 is an important factor in hepatic regeneration after partial hepatectomy in mice |
| Q36036273 | Metabolic Profile Changes of CCl₄-Liver Fibrosis and Inhibitory Effects of Jiaqi Ganxian Granule. |
| Q64964605 | MicroRNA‑219 overexpression serves a protective role during liver fibrosis by targeting tumor growth factor β receptor 2. |
| Q28303698 | Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets |
| Q34603561 | Muscle ring finger 1 mediates cardiac atrophy in vivo |
| Q38639324 | Oncostatin M causes liver fibrosis by regulating cooperation between hepatic stellate cells and macrophages in mice |
| Q39337824 | Osteopontin contributes to TGF-β1 mediated hepatic stellate cell activation |
| Q37293878 | Oval cell proliferation in p16INK4a expressing mouse liver is triggered by chronic growth stimuli. |
| Q38759957 | Pentoxifylline inhibits liver fibrosis via hedgehog signaling pathway |
| Q24556510 | Platelet-derived growth factor C induces liver fibrosis, steatosis, and hepatocellular carcinoma |
| Q28238030 | Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes |
| Q48124826 | Response of Hepatic Stellate Cells to TGFB1 Differs from the Response of Myofibroblasts. Decorin Protects against the Action of Growth Factor |
| Q41879536 | Response of sinusoidal mouse liver cells to choline-deficient ethionine-supplemented diet |
| Q33632736 | Role of NADPH oxidases in liver fibrosis |
| Q43105330 | S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis. |
| Q46641842 | Signal transduction in alcohol-related diseases |
| Q85887123 | Smad2 protects against TGF-β1/Smad3-mediated collagen synthesis in human hepatic stellate cells during hepatic fibrosis |
| Q37257648 | Smad3 reduces susceptibility to hepatocarcinoma by sensitizing hepatocytes to apoptosis through downregulation of Bcl-2. |
| Q41152963 | Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model |
| Q52583529 | Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart. |
| Q36187040 | TGF-beta inhibitors for the treatment of cancer |
| Q37946756 | TGF-β in progression of liver disease |
| Q37587875 | Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. |
| Q89769221 | The balancing act of the liver: tissue regeneration versus fibrosis |
| Q89509450 | Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies |
| Q41496328 | Transarterial chemoembolization aggravated peritumoral fibrosis via hypoxia-inducible factor-1α dependent pathway in hepatocellular carcinoma |
| Q91714322 | Transforming Growth Factor-Beta1 in Diabetic Kidney Disease |
| Q39344643 | Transforming growth factor beta1 gene variation Leu10Pro affects secretion and function in hepatic cells |
| Q46112010 | Transforming growth factor-beta type 1 receptor (ALK5) and Smad proteins mediate TIMP-1 and collagen synthesis in experimental intestinal fibrosis |
| Q35010511 | Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection |
| Q50104779 | Transforming growth factor-β in stem cells and tissue homeostasis |
| Q36810701 | Transforming growth factor-β1 and diabetic nephropathy |
| Q34033449 | Tubular overexpression of transforming growth factor-beta1 induces autophagy and fibrosis but not mesenchymal transition of renal epithelial cells |
Search more.